Clinical Trial: A Clinical Trial of MK-6916 With Midazolam and Rosuvastatin in Healthy Participants (MK-6916-012)

U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07862621) titled 'A Clinical Trial of MK-6916 With Midazolam and Rosuvastatin in Healthy Participants (MK-6916-012)' on Oct. 02.

Brief Summary: Researchers are looking for new treatments for pain. The goal of this trial is to learn if MK-6916 changes what happens to the midazolam and rosuvastatin in healthy participants' bodies. Researchers will compare the amount of midazolam and rosuvastatin in a participant's body over time when they are given with and without MK-6916.

Study Start Date: Nov. 30

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Midazolam

Administered orally on Day 1 of Period 1 and on Days 2 and 14 of Period 2...